Concepedia

Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine

Darron R. Brown, Kenneth H. Fife, Cosette M. Wheeler, Laura A. Koutsky, Lisa Lupinacci, Radha Railkar, Gretchen Suhr, Eliav Barr, ANTHONY C. DiCELLO, Weili Li,

Vaccine · 2004 · 88 citations · 21 references

DOI

Concepts

References

21

Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

F. Xavier Bosch, M. Michele Manos, Mark E. Sherman et al. · JNCI Journal of the National Cancer Institute · 1995 · 3.4K citations

, , +17

A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

Laura A. Koutsky, Kevin A. Ault, Cosette M. Wheeler et al. · New England Journal of Medicine · 2002 · 1.6K citations · Full text

, , +17

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

Gloria Y. F. Ho, Robert D. Burk, S. Klein et al. · JNCI Journal of the National Cancer Institute · 1995 · 818 citations

, , +17

Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study

Marielle Nobbenhuis, Jan M.M. Walboomers, Theo J.M. Helmerhorst et al. · The Lancet · 1999 · 703 citations

, , +17

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.

JoAnn Suzich, S. Ghim, Frances J. Palmer‐Hill et al. · Proceedings of the National Academy of Sciences · 1995 · 671 citations

, , +17